TEAM
Camille LAURENT
NoLymIT :
New Immunotherapies Against Lymphoma
The Toulouse Cancer Laboratory of Excellence is a project that aims to understand the mechanisms of resistance and relapse in cancer
THE SPECIFIties
OF OUR RESEARCH AXIS
Our work focuses on the innate and adaptive immune responses in lymphoma with a special emphasis on the study of γδ T cells and the mechanisms of regulation of immune checkpoint expression.
Recently, we have introduced single cell RNAseq techniques and developed bionformatics tools allowing us to explore the functional status and maturation/differentiation stage of cytotoxic effectors at the single cell level in lymphoma lymph node or blood samples.
The privileged access to different cohorts of lymphoma patients has also allowed us to identify biomarkers of response in lymphoma and establish a screening platform based on 3D models from lymphoma patients’ samples.
B lymphoma/LLC
 microenvironment & gamma delta T cells
 immune escape mechanisms & post-transcriptional regulation
of immune checkpoints
biomarkers of response/progression
3D models
therapeutic screenings
single cell RNAseq
 bioinformatics tools
RESEARCH PROJECTS
Single cell mapping of γδT cells and vasculature in lymphoma: a study for localization and functional characterization of γδ lymphocytes infiltrating human lymphomas.
Pr Camille Laurent
Characterization and therapeutic targeting of a new immunoregulatory mechanism
 Dr Don Marc Franchini
Leukemia and immune cell resistance to targeted therapies in chronic lymphocytic leukemia (cll)
Dr Anne Quillet-Mary
Identification of immuno-escapement mechanisms by multiomics approaches.
Pr Camille Laurent
PDLS at the heart of the identification of new therapeutic targets in NHL
Dr Christine Bezombes
THE TEAM’S
FOCUS
Discover
Understand
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.